XML 62 R36.htm IDEA: XBRL DOCUMENT
v3.25.4

Stock-based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract] |
Schedule of Black-Scholes Option Pricing Model Assumptions | The following table presents 1) assumptions used in the Black-Scholes option pricing model to determine the estimated grant date fair values of stock options and SARS granted to employees; and 2) options and SARS granted and weighted average grant date fair value.
| Years Ended December 31,
| 2025 |  | 2024 |  | 2023
(Shares in thousands) |
Weighted average expected life (years) | 4.2 |  | 4.0 |  | 9.1
Weighted average expected volatility | 50.5% |  | 49.0% |  | 60.4%
Risk-free interest rate | 3.50% – 4.13% |  | 3.52% – 4.54% |  | 3.87% – 3.87%
Weighted average dividend yield | —% |  | —% |  | —%
Stock options and SARS granted | 144 |  | 721 |  | 14
Weighted average grant date fair value | $6.08 |  | $6.36 |  | $8.72
Schedule of Forfeiture Rates | The following table presents the estimated weighted average forfeiture rates for all employees used in determining the expense in the stock-based compensation expense table above.
| Years Ended December 31,
| 2025 |  | 2024 |  | 2023
Stock options, SARS, RSUs and PRSUs | 6.4% |  | 6.3% |  | 6.4%
Schedule of Share-based Compensation Expense | The following table presents the s tock-based compensation expense related to the fair value measurement of awards granted to employees by expense category and by type of award. All stock-based payment awards are amortized on a straight-line basis over the requisite service periods of the awards.
| Years Ended December 31,
| 2025 |  | 2024 |  | 2023
(In thousands) |
Stock-based compensation expense charged to: |  |  |  |  |
Cost of revenue | $543 |  | $1,076 |  | $719
General and administrative | 3,307 |  | 4,013 |  | 3,661
Sales and marketing | 2,859 |  | 3,489 |  | 2,333
Research and development | 1,010 |  | 1,744 |  | 1,325
Total stock-based compensation expense | $7,719 |  | $10,322 |  | $8,038
Stock-based compensation expense by type of award: |  |  |  |  |
Stock options and SARS | $1,502 |  | $2,334 |  | $1,985
RSUs | 6,217 |  | 7,988 |  | 6,053
Total stock-based compensation expense | $7,719 |  | $10,322 |  | $8,038
Schedule of Stock Option Activity | The following table presents stock option and SARS activities under the Equity Incentive Plans.
| Number of Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life |  | Aggregate Intrinsic Value(1)
| (In thousands) |  | (Per share) |  | (In years) |  | (In thousands)
Balance, December 31, 2022 | 2,421 |  | $11.02 |  |  |  |
Granted | 14 |  | 22.13 |  |  |  |
Exercised | (511) |  | 9.38 |  |  |  | $5,619
Balance, December 31, 2023 | 1,924 |  | 11.54 |  |  |  |
Granted | 721 |  | 15.02 |  |  |  |
Exercised | (767) |  | 9.26 |  |  |  | 5,260
Forfeited | (270) |  | 18.06 |  |  |  |
Balance, December 31, 2024 | 1,608 |  | 13.09 |  |  |  |
Granted | 144 |  | 14.74 |  |  |  |
Exercised | (269) |  | 8.93 |  |  |  | 1,664
Forfeited | (86) |  | 15.49 |  |  |  |
Balance, December 31, 2025 | 1,397 |  | $13.91 |  | 6.5 |  | $1,758
Vested and exercisable as of December 31, 2025 | 839 |  | $13.18 |  | 5.0 |  | $1,671
Vested and exercisable as of December 31, 2025 and expected to vest thereafter | 1,345 |  | $13.87 |  | 6.4 |  | $1,750
(1)The aggregate intrinsic value of an exercised option and SARS is calculated as the difference between the exercise price of the underlying option and SARS and the fair value of the Company’s common stock at the time of exercise. The aggregate intrinsic value at December 31, 2025 is calculated as the difference between the exercise price of the underlying outstanding options and SARS and the fair value of the Company’s common stock as of December 31, 2025 or the last trading day prior to December 31, 2025.
Schedule of Restricted Stock Units Activity | The following table presents RSU activities under the Equity Incentive Plans.
| Number of Shares |  | Weighted Average Grant Date Fair Value
| (In thousands) |  | (Per share)
Balance, December 31, 2022 | 688 |  | $15.51
Awarded | 546 |  | 23.97
Vested | (294) |  | 14.02
Forfeited | (21) |  | 19.91
Balance, December 31, 2023 | 919 |  | 20.91
Awarded | 751 |  | 14.85
Vested | (389) |  | 18.79
Forfeited | (281) |  | 20.70
Balance, December 31, 2024 | 1,000 |  | 17.24
Awarded | 707 |  | 14.48
Vested | (367) |  | 17.34
Forfeited | (277) |  | 16.55
Balance, December 31, 2025 | 1,063 |  | 15.56
The following table presents PRSU activities under the Equity Incentive Plans.
| Number of Shares |  | Weighted Average Grant Date Fair Value
| (In thousands) |  | (Per share)
Balance, December 31, 2024 | — |  | $—
Awarded | 305 |  | 14.69
Vested | — |  | —
Forfeited | (23) |  | 15.05
Balance, December 31, 2025 | 281 |  | 14.66
Schedule of Vested Stock Options and RSUs | The following table presents the total grant date fair value of equity awards vested during the period.
| Years Ended December 31,
| 2025 |  | 2024 |  | 2023
(In thousands) |
Stock options and SARs | $1,991 |  | $857 |  | $2,724
RSUs | 6,365 |  | 7,298 |  | 4,112
PRSUs | — |  | — |  | —
Total grant date fair value of equity awards vested during the period | $8,356 |  | $8,155 |  | $6,836
Schedule of Unamortized Compensation Cost and Weighted Average Service Period | The following table presents the unamortized compensation costs and weighted average service period of all unvested outstanding awards as of December 31, 2025.
| Unamortized Compensation Costs |  | Weighted Average Service Period
| (In thousands) |  | (In years)
Stock options and SARs | $2,922 |  | 2.0
RSUs | 10,079 |  | 1.3
PRSUs | 3,158 |  | 2.0
Total unamortized compensation costs, net of adjusted forfeitures | $16,159 |  |

X
- Definition Schedule Of Forfeiture Rates [Table Text Block] + References No definition available. + Details
Name: | erii_ScheduleOfForfeitureRatesTableTextBlock
Namespace Prefix: | erii_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Grant Date Fair Value Of Equity Instruments Vested [Table Text Block] + References No definition available. + Details
Name: | erii_ScheduleOfGrantDateFairValueOfEquityInstrumentsVestedTableTextBlock
Namespace Prefix: | erii_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Share-Based Payment Award, Valuation Assumptions + References No definition available. + Details
Name: | erii_ScheduleOfShareBasedPaymentAwardValuationAssumptionsTableTextBlock
Namespace Prefix: | erii_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Unamortized Compensation Cost And Weighted Average Service Period [Table Text Block] + References No definition available. + Details
Name: | erii_ScheduleOfUnamortizedCompensationCostAndWeightedAverageServicePeriodTableTextBlock
Namespace Prefix: | erii_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration